Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery

Recruiting now · Phase 2

Conditions studied: Pancreatic Adenocarcinoma

In brief

This is a single-arm, single-center feasibility trial of patients with borderline resectable pancreatic adenocarcinoma receiving chemotherapy with mFOLFIRINOX or gemcitabine / nab-paclitaxel followed by pancreatectomy.

Key facts

Study ID
NCT04452461
Run by
Hamilton Health Sciences Corporation
People needed
30
Starts
2021-03-01
Expected to finish
2026-05-01
Last updated by the study team
2024-10-10

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.